MAP2K7 and blindness (disorder): Significant cases of uveitis or VKH-like syndrome linked to BRAF inhibitors or immunotherapy, vascular occlusions, or ischemic optic neuropathy caused by MEK inhibitors are of the greatest concern because they can cause permanent deterioration of vision, or even blindness.